\-\ Texto\\:\\ \ \(0\)\
\-\ hyperdense\\ liver\\ on\\ a\\ non\\-contrast\\ chest\\ ct\\.\\ \\ normal\\ attenuation\\ of\\ the\\ spleen\\ and\\ remainder\\ of\\ visualized\\ organs\\.\ \(0\)\
\-\ amiodarone\\ deposition\\ in\\ the\\ liver\ \(0\)\
\-\ \\â\\€\\¢\\ amiodarone\\ use\ \(0\)\
\-\ \\â\\€\\¢\\ primary\\ hemochromatosis\ \(0\)\
\-\ \\â\\€\\¢\\ wilson\\ disease\ \(0\)\
\-\ \\â\\€\\¢\\ gold\\ treatments\ \(0\)\
\-\ \\â\\€\\¢\\ thorotrast\\ exposure\ \(0\)\
\-\ 85\\ year\\ old\\ woman\\ with\\ dyspnea\\.\ \(1\)\
\-\ the\\ chest\\ ct\\ was\\ requested\\ in\\ the\\ patient\\ to\\ search\\ for\\ pulmonary\\ findings\\ of\\ amiodarone\\ toxicity\\,\\ \\ the\\ lungs\\,\\ aside\\ from\\ mild\\ emphysematous\\ changes\\ \\(not\\ shown\\)\\ were\\ rather\\ unremarkable\\.\\ \\ the\\ liver\\ findings\\ were\\ incidental\\ \\(but\\ not\\ unexpected\\)\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ amiodarone\\:\\ 0\\.21709777769908176\ \(0\)\
\-\ liver\\:\\ 0\\.09820738369442412\ \(0\)\
\-\ thorotrast\\:\\ 0\\.09024856937118393\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.08705635286643822\ \(0\)\
\-\ toxicity\\:\\ 0\\.06647005644344758\ \(0\)\
\-\ aside\\:\\ 0\\.06647005644344758\ \(0\)\
\-\ hemochromatosis\\:\\ 0\\.06583496295633705\ \(0\)\
\-\ wilson\\:\\ 0\\.06360528856231314\ \(0\)\
\-\ unexpected\\:\\ 0\\.06311138008930388\ \(0\)\
\-\ gold\\:\\ 0\\.06263849548465059\ \(0\)\
\-\ search\\:\\ 0\\.061749132066055736\ \(0\)\
\-\ emphysematous\\:\\ 0\\.060925710153236605\ \(0\)\
\-\ requested\\:\\ 0\\.055409744749748926\ \(0\)\
\-\ treatments\\:\\ 0\\.05493686014509564\ \(0\)\
\-\ organs\\:\\ 0\\.05448328242820391\ \(0\)\
\-\ deposition\\:\\ 0\\.05302741284591054\ \(0\)\
\-\ 85\\:\\ 0\\.05302741284591054\ \(0\)\
\-\ spleen\\:\\ 0\\.05106678576433769\ \(0\)\
\-\ exposure\\:\\ 0\\.04940078412777197\ \(0\)\
\-\ hyperdense\\:\\ 0\\.047469151574405496\ \(0\)\
\-\ non\\-contrast\\:\\ 0\\.046345861386945846\ \(0\)\
\-\ chest\\:\\ 0\\.04543842222350042\ \(0\)\
\-\ rather\\:\\ 0\\.045132535920668154\ \(0\)\
\-\ dyspnea\\:\\ 0\\.04494259777223148\ \(0\)\
\-\ remainder\\:\\ 0\\.04475585201316058\ \(0\)\
\-\ were\\:\\ 0\\.04311747414866492\ \(0\)\
\-\ findings\\:\\ 0\\.04041859857311022\ \(0\)\
\-\ visualized\\:\\ 0\\.0384325794366054\ \(0\)\
\-\ attenuation\\:\\ 0\\.03817356744917821\ \(0\)\
\-\ shown\\:\\ 0\\.03807162993499997\ \(0\)\
\-\ use\\:\\ 0\\.03752710127825892\ \(0\)\
\-\ lungs\\:\\ 0\\.035953206644225286\ \(0\)\
\-\ incidental\\:\\ 0\\.035953206644225286\ \(0\)\
\-\ unremarkable\\:\\ 0\\.03143407131868956\ \(0\)\
\-\ primary\\:\\ 0\\.02812649180995218\ \(0\)\
\-\ pulmonary\\:\\ 0\\.027739447891334038\ \(0\)\
\-\ not\\:\\ 0\\.027440414927598564\ \(0\)\
\-\ changes\\:\\ 0\\.02721164418038956\ \(0\)\
\-\ ct\\:\\ 0\\.026562303408712067\ \(0\)\
\-\ mild\\:\\ 0\\.02500281615479041\ \(0\)\
\-\ woman\\:\\ 0\\.02193225497209896\ \(0\)\
\-\ but\\:\\ 0\\.02025003667815042\ \(0\)\
\-\ \\(\\:\\ 0\\.016052482805419124\ \(0\)\
\-\ \\)\\:\\ 0\\.015856393158073447\ \(0\)\
\-\ disease\\:\\ 0\\.015519306013507825\ \(0\)\
\-\ normal\\:\\ 0\\.014884582828878902\ \(0\)\
\-\ from\\:\\ 0\\.014071507923935692\ \(0\)\
\-\ was\\:\\ 0\\.010980861357929854\ \(0\)\
\-\ year\\:\\ 0\\.010623391880810164\ \(0\)\
\-\ old\\:\\ 0\\.009721495520691719\ \(0\)\
\-\ patient\\:\\ 0\\.0095176881212932\ \(0\)\
\-\ in\\:\\ 0\\.009364382892005665\ \(0\)\
\-\ the\\:\\ 0\\.00921661898024172\ \(0\)\
\-\ for\\:\\ 0\\.008101201651585723\ \(0\)\
\-\ on\\:\\ 0\\.008043233470726979\ \(0\)\
\-\ \\,\\:\\ 0\\.006015779233717497\ \(0\)\
\-\ to\\:\\ 0\\.00474520120492207\ \(0\)\
\-\ a\\:\\ 0\\.004406664464651125\ \(0\)\
\-\ of\\:\\ 0\\.0038834600265996145\ \(0\)\
\-\ and\\:\\ 0\\.0020001000636913164\ \(0\)\
\-\ \\.\\:\\ 0\\.001972196449852571\ \(0\)\
\-\ with\\:\\ 0\\.001300046400998775\ \(0\)\
